Trailing-twelve-month (TTM) revenue is $794.64 Million with a year-over-year growth of +11.46%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $185,891,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2026-01-03 | $196,963,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-04-04 | $200,975,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-07-04 | $210,815,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $794,644,000 |
Current P/S: $1,109,219,240 market capitalization ÷ $794,644,000 TTM revenue = 1.40x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:20:05.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-04): $210.81M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:21:21.296Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|
| Fixed-Price Contract | $110M | $114M | $127M | $131M |
| Time-and-Materials Contract | $481M | $510M | $561M | $621M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|---|
| Countries Other Than United States United Kingdom | $23M | $28M | $31M | $36M | $42M | $48M |
| UNITED KINGDOM | $80M | $86M | $89M |
$794.64M
$794.64 Million
+11.46%
vs. $712.94M a year ago (TTM)
+7.48%
5 Year compound annual growth rate
1 Year
+11.46%
3 Year
+9.29%
5 Year
+7.48%
10 Year
+9.78%
15 Year
+6.74%
20 Year
+4.57%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $751.58M | +$64.17M | +9.33% |
| 2024 | $687.41M | +$63.44M | +10.17% |
| 2023 | $623.98M | +$33.08M | +5.60% |
| 2022 | $590.90M | +$24.97M | +4.41% |
| 2021 | $565.93M | +$57.56M | +11.32% |
| 2020 |
TTM Growth
+11.46%
3-Year CAGR
+9.29%
5-Year CAGR
+7.48%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:21:21.296Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $87M |
| $101M |
| UNITED STATES | $406M | $451M | $470M | $494M | $559M | $602M |
|---|
| $508.37M |
| +$57.00M |
| +12.63% |
| 2019 | $451.37M | +$33.72M | +8.07% |
| 2018 | $417.65M | +$47.57M | +12.85% |
| 2017 | $370.07M | +$45.30M | +13.95% |
| 2016 | $324.78M | +$21.22M | +6.99% |
